Cost Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes Mellitus in Greece
Crossref DOI link: https://doi.org/10.1007/s40261-017-0586-0
Published Online: 2017-10-27
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tzanetakos, Charalampos
Bargiota, Alexandra
Kourlaba, Georgia
Gourzoulidis, George
Maniadakis, Nikos
License valid from 2017-10-27